(688443)"CHONGQING GENRIX BIOPHARMACEUTICAL CO., LTD."Announcement on Change of Signing Certified Public Accountant
Filed with SSE · Stock code 688443 · · 2 pages · Chinese
Summary by 6ix AI
Chongqing Genrix Biopharmaceutical Co., Ltd. announced a change in its signing certified public accountant.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Chongqing Genrix Biopharmaceutical Co., Ltd. on 6ix
Story so far
- Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Chongqing Jurisdiction and Semi-annual Performance Briefing
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Announcement on Voluntary Disclosure of the Conditional Approval for Marketing of Velinotamig Injection
Earlier from Chongqing Genrix Biopharmaceutical
- Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Chongqing Jurisdiction and Semi-annual Performance Briefing
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
- Announcement on Voluntary Disclosure of the Conditional Approval for Marketing of Velinotamig Injection
- Announcement on Voluntary Disclosure of Obtaining the Notice of Approval for Clinical Trial of GR2302 Injection for the Indication of Chronic Hepatitis B
Later from Chongqing Genrix Biopharmaceutical
All Chongqing Genrix Biopharmaceutical news releasesFollow Chongqing Genrix Biopharmaceutical into a list and get an email when it puts out news.
Follow Chongqing Genrix Biopharmaceutical